Cargando…

Lipocalin 2 stimulates bone fibroblast growth factor 23 production in chronic kidney disease

Bone-produced fibroblast growth factor 23 (FGF23) increases in response to inflammation and iron deficiency and contributes to cardiovascular mortality in chronic kidney disease (CKD). Neutrophil gelatinase-associated lipocalin (NGAL or lipocalin 2; LCN2 the murine homolog) is a pro-inflammatory and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Courbon, Guillaume, Francis, Connor, Gerber, Claire, Neuburg, Samantha, Wang, Xueyan, Lynch, Emily, Isakova, Tamara, Babitt, Jodie L., Wolf, Myles, Martin, Aline, David, Valentin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8326281/ https://www.ncbi.nlm.nih.gov/pubmed/34334787 http://dx.doi.org/10.1038/s41413-021-00154-0

Ejemplares similares

Inflammation and functional iron deficiency regulate fibroblast growth factor 23 production
por: David, Valentin, et al.
Publicado: (2016)

DMP1 prevents osteocyte alterations, FGF23 elevation and left ventricular hypertrophy in mice with chronic kidney disease
por: Dussold, Corey, et al.
Publicado: (2019)

Long‐Term Effects of Sglt2 Deletion on Bone and Mineral Metabolism in Mice
por: Gerber, Claire, et al.
Publicado: (2021)

Fibroblast Growth Factor 23 and Incident Cardiovascular Disease and Mortality in Middle‐Aged Adults
por: Paul, Shejuti, et al.
Publicado: (2021)

Bone-derived C-terminal FGF23 cleaved peptides increase iron availability in acute inflammation
por: Courbon, Guillaume, et al.
Publicado: (2023)

UPDATE ON FIBROBLAST GROWTH FACTOR 23 IN CHRONIC KIDNEY DISEASE
por: Wolf, Myles
Publicado: (2012)

Plasma Serotonin and Cardiovascular Outcomes in Chronic Kidney Disease
por: Edmonston, Daniel, et al.
Publicado: (2023)

Osteokines and the vasculature: a review of the in vitro effects of osteocalcin, fibroblast growth factor-23 and lipocalin-2
por: Millar, Sophie A., et al.
Publicado: (2019)

Fibroblast growth factor 23 is not associated with and does not induce arterial calcification
por: Scialla, Julia J., et al.
Publicado: (2013)

Associations of FGF23 with 10-Year Change in eGFR and UACR and with Incident CKD in the CARDIA Cohort
por: Sunderraj, Ashwin, et al.
Publicado: (2023)

Fibroblast Growth Factor 23 and Risk of Heart Failure Subtype: The CRIC (Chronic Renal Insufficiency Cohort) Study
por: Leidner, Alexander S., et al.
Publicado: (2023)

Neutrophil Gelatinase-Associated Lipocalin, Fibroblast Growth Factor 23, and Soluble Klotho in Long-Term Kidney Donors
por: Thorsen, Inga Strand, et al.
Publicado: (2016)

The link between bone-derived factors osteocalcin, fibroblast growth factor 23, sclerostin, lipocalin 2 and tumor bone metastasis
por: Martiniakova, Monika, et al.
Publicado: (2023)

The effects of tenapanor on serum fibroblast growth factor 23 in patients receiving hemodialysis with hyperphosphatemia
por: Block, Geoffrey A, et al.
Publicado: (2019)

Hemojuvelin and bone morphogenetic protein (BMP) signaling in iron homeostasis
por: Core, Amanda B., et al.
Publicado: (2014)

Fibroblast growth factor23 is associated with axonal integrity and neural network architecture in the human frontal lobes
por: Marebwa, Barbara K., et al.
Publicado: (2018)

A Lipocalin-Derived Peptide Modulating Fibroblasts and Extracellular Matrix Proteins
por: Carrijo-Carvalho, Linda Christian, et al.
Publicado: (2012)

Effects of etelcalcetide on fibroblast growth factor 23 in patients with secondary hyperparathyroidism receiving hemodialysis
por: Wolf, Myles, et al.
Publicado: (2019)

Lipocalin-2 is associated with FGF23 in WNT1 and PLS3 osteoporosis
por: Loid, Petra, et al.
Publicado: (2022)

Hyperphosphatemia increases inflammation to exacerbate anemia and skeletal muscle wasting independently of FGF23-FGFR4 signaling
por: Czaya, Brian, et al.
Publicado: (2022)

Tear Lipocalin and Lipocalin-Interacting Membrane Receptor
por: Glasgow, Ben J.
Publicado: (2021)

Repulsive Guidance Molecule (RGM) Family Proteins Exhibit Differential Binding Kinetics for Bone Morphogenetic Proteins (BMPs)
por: Wu, Qifang, et al.
Publicado: (2012)

LipocalinPred: a SVM-based method for prediction of lipocalins
por: Ramana, Jayashree, et al.
Publicado: (2009)

FGF-23: More Than a Regulator of Renal Phosphate Handling?
por: Jüppner, Harald, et al.
Publicado: (2010)

Dimerization of lipocalin allergens
por: Niemi, Merja H., et al.
Publicado: (2015)

Lipocalin-2 in Stroke
por: Chou, Wen-Hai, et al.
Publicado: (2015)

Design and Rationale of HiLo: A Pragmatic, Randomized Trial of Phosphate Management for Patients Receiving Maintenance Hemodialysis
por: Edmonston, Daniel L., et al.
Publicado: (2021)

Fibroblast Growth Factor 23 Stimulates Cardiac Fibroblast Activity through Phospholipase C-Mediated Calcium Signaling
por: Lee, Ting-Wei, et al.
Publicado: (2021)

Fibroblast Growth Factor 23 (FGF23) and Disorders of Phosphate Metabolism
por: Saito, Tasuku, et al.
Publicado: (2009)

PKC regulates the production of fibroblast growth factor 23 (FGF23)
por: Bär, Ludmilla, et al.
Publicado: (2019)

The Measurement and Interpretation of Fibroblast Growth Factor 23 (FGF23) Concentrations
por: Heijboer, Annemieke C., et al.
Publicado: (2022)

Lipocalins in Arthropod Chemical Communication
por: Zhu, Jiao, et al.
Publicado: (2021)

Lipocalin-2 and Cerebral Stroke
por: Luo, Chao, et al.
Publicado: (2022)

Glucocorticoids dexamethasone and prednisolone suppress fibroblast growth factor 23 (FGF23)
por: Feger, Martina, et al.
Publicado: (2021)

Role of Fibroblast Growth Factor 23 (FGF23) and αKlotho in Cancer
por: Ewendt, Franz, et al.
Publicado: (2021)

Transcription factor HNF4α2 promotes osteogenesis and prevents bone abnormalities in mice with renal osteodystrophy
por: Martinez-Calle, Marta, et al.
Publicado: (2023)

Fibroblast growth factor 23 and bone mineralisation
por: Guo, Yu-Chen, et al.
Publicado: (2015)

Physiological Actions of Fibroblast Growth Factor-23
por: Erben, Reinhold G.
Publicado: (2018)

Upstream Regulators of Fibroblast Growth Factor 23
por: Ratsma, Danielle M. A., et al.
Publicado: (2021)

Phosphate and fibroblast growth factor 23 in diabetes
por: van der Vaart, Amarens, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_q905nks5mpgupjbi228aqgtjqq